PITCOIN-4

N/A

Report date: 2023/11/01 17:30:49
NME

Base Information

Drug NamePITCOIN-4
Drug Alias NamePITCOIN4PITCOIN-4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha inhibitors
TargetsPhosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLeibniz-Forschungsinstitut für Molekulare Pharmakologie
China Registration ClassN/A

Develop Information

Active CompaniesLeibniz-Forschungsinstitut für Molekulare Pharmakologie
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A